← Human Trials & Peer-Reviewed Studies

Circulating Piwi-Interacting RNAs Associate With Childhood Asthma ICS Response With Vitamin D Effect Modification.

Plain-language guide to PMID 42010358 (2026): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 492 participants.

Key Facts

PMID
42010358
Journal
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Year
2026
Study type
Randomized Controlled Trial
Authors
Li J et al. (12 authors)
DOI
10.1111/cea.70314
Registered trial
NCT00000575, NCT00021840

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Piwi-interacting RNAs (piRNAs) have been linked to type 2-high asthma phenotypes.

Although vitamin D modulates inhaled corticosteroid (ICS) response via microRNAs, its potential role through piRNAs remains unknown.

Who Took Part

The study group was 492 participants.

PubMed indexes the participants as children, both men and women.

Baseline plasma piRNA expression was profiled by small RNA sequencing in 492 participants from the Childhood Asthma Management Program (CAMP), with 187 children randomised to the ICS arm.

Replication was performed in 375 ICS-treated participants from the Genetics of Asthma in Costa Rica Study (GACRS).

How the Study Was Run

The design is described as randomized.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Serum vitamin D levels were classified as insufficient (≤ 30 ng/mL) or sufficient (> 30 ng/mL).

What Was Measured

PubMed files the paper under topics including Administration, Inhalation, Adrenal Cortex Hormones, Asthma, Biomarkers, Piwi-Interacting RNA and Vitamin D.

Author keywords: childhood asthma, circulating piRNA and inhaled corticosteroids.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 492 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.